CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
The Proteasome Inhibitor Bortezomib and Oncolytic Virotherapy act synergistically in hepatocellular carcinoma
DOI 10.1055/s-2008-1037517
Bibliografische Angaben
Nachweis in CareLit
Autor:innenB Boozari, TC Wirth, N Woller, MP Manns, S Kubicka, F Kühnel
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Oncolytic Therapy using conditionally replicating adenoviral vectors provides a challenging tool for the treatment of solid tumors. Recently, the proteasome inhibitor Bortezomib has been established as novel anti-cancer agent. However, exact molecular mechanisms of Bortezomib induced cell death are not fully understood and potential interference with virotherapy if applied as combination treatment is unkown. Aim of…
Zitieren
Zitierempfehlung
B Boozari, TC Wirth, N Woller, MP Manns, S Kubicka, F Kühnel (2008) The Proteasome Inhibitor Bortezomib and Oncolytic Virotherapy act synergistically in hepatocellular carcinoma. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-2008-1037517
Mit CareLit weiterarbeiten